(Q58455666)
Statements
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance (English)
V Grossmann
A Kohlmann
C Eder
W Kern
S Schnittger
C Haferlach
22 February 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference